Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

R. T. Swords, J. Watts, H. P. Erba, J. K. Altman, M. Maris, F. Anwer, Z. Hua, H. Stein, H. Faessel, F. Sedarati, B. J. Dezube, F. J. Giles, B. C. Medeiros, D. J. DeAngelo

Research output: Contribution to journalLetterpeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes'. Together they form a unique fingerprint.